
    
      Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Withdrawal Study of
      Pulmonary Arterial Hypertension(PAH) Subjects with LTOT Use that have Demonstrated Improved
      Exercise Tolerance with the use of Inhaled Nitric Oxide (INO)
    
  